- Diseases
- Acoustic Neuroma (14)
- Adrenal Gland Tumor (24)
- Anal Cancer (68)
- Anemia (2)
- Appendix Cancer (16)
- Bile Duct Cancer (26)
- Bladder Cancer (68)
- Brain Metastases (28)
- Brain Tumor (230)
- Breast Cancer (720)
- Breast Implant-Associated Anaplastic Large Cell Lymphoma (2)
- Cancer of Unknown Primary (4)
- Carcinoid Tumor (8)
- Cervical Cancer (156)
- Colon Cancer (164)
- Colorectal Cancer (112)
- Endocrine Tumor (4)
- Esophageal Cancer (42)
- Eye Cancer (36)
- Fallopian Tube Cancer (8)
- Germ Cell Tumor (4)
- Gestational Trophoblastic Disease (2)
- Head and Neck Cancer (8)
- Kidney Cancer (126)
- Leukemia (344)
- Liver Cancer (50)
- Lung Cancer (286)
- Lymphoma (284)
- Mesothelioma (14)
- Metastasis (30)
- Multiple Myeloma (98)
- Myelodysplastic Syndrome (60)
- Myeloproliferative Neoplasm (4)
- Neuroendocrine Tumors (16)
- Oral Cancer (100)
- Ovarian Cancer (172)
- Pancreatic Cancer (164)
- Parathyroid Disease (2)
- Penile Cancer (14)
- Pituitary Tumor (6)
- Prostate Cancer (144)
- Rectal Cancer (58)
- Renal Medullary Carcinoma (6)
- Salivary Gland Cancer (14)
- Sarcoma (236)
- Skin Cancer (296)
- Skull Base Tumors (56)
- Spinal Tumor (12)
- Stomach Cancer (60)
- Testicular Cancer (28)
- Throat Cancer (90)
- Thymoma (6)
- Thyroid Cancer (96)
- Tonsil Cancer (30)
- Uterine Cancer (80)
- Vaginal Cancer (16)
- Vulvar Cancer (20)
- Cancer Topic
- Adolescent and Young Adult Cancer Issues (20)
- Advance Care Planning (10)
- Biostatistics (2)
- Blood Donation (18)
- Bone Health (8)
- COVID-19 (362)
- Cancer Recurrence (120)
- Childhood Cancer Issues (120)
- Clinical Trials (632)
- Complementary Integrative Medicine (24)
- Cytogenetics (2)
- DNA Methylation (4)
- Diagnosis (230)
- Epigenetics (6)
- Fertility (62)
- Follow-up Guidelines (2)
- Health Disparities (14)
- Hereditary Cancer Syndromes (124)
- Immunology (18)
- Li-Fraumeni Syndrome (8)
- Mental Health (118)
- Molecular Diagnostics (8)
- Pain Management (62)
- Palliative Care (8)
- Pathology (10)
- Physical Therapy (18)
- Pregnancy (18)
- Prevention (908)
- Research (396)
- Second Opinion (74)
- Sexuality (16)
- Side Effects (606)
- Sleep Disorders (10)
- Stem Cell Transplantation Cellular Therapy (216)
- Support (402)
- Survivorship (322)
- Symptoms (184)
- Treatment (1784)
Breast reconstruction rates increase following mastectomies
2 minute read | Published March 04, 2014
Medically Reviewed | Last reviewed by an MD Anderson Cancer Center medical professional on March 04, 2014
Women who underwent a mastectomy as part of their treatment for breast cancer are increasingly opting for reconstructive surgery, according to new research published in the Journal of Clinical Oncology.
The observational study, led by MD Anderson and The University of Michigan, evaluated insurance claims from 20,506 women from 1998-2007 and found a nearly 20 percent increase in breast reconstruction. The research also noted bilateral mastectomies (removal of both breasts) increased from 3 percent to 18 percent over the same period.
While overall rates of reconstruction increased, women who received radiation therapy were less likely to have reconstructive procedures.
"In appropriately selected patients radiation saves lives and is generally well-tolerated, however, radiation does cause a certain degree of damage to normal tissue which complicates and often delays breast reconstruction," said senior author Benjamin Smith, M.D., in Radiation Oncology.
The study also provided further insight into regional disparities that exist with regard to reconstructive procedures. Smith and colleagues found a dramatic geographic variation of reconstruction from a low of 18% in North Dakota to a high of 80% in Washington D.C.
This particular finding was largely related to the number of surgeons in the area, however, concerns exist that patients are not receiving appropriate care based on their location.
Additional findings showed that the rates of autologous reconstructive techniques (recreating breasts using tissue from other parts of the body) decreased as more women opted for implant-based reconstruction. While autologous techniques often deliver improved cosmetic appearance, they are more complex and require a longer recovery time.
The authors say reimbursement rates could be the culprit as surgeons face financial disincentives from performing longer, more demanding reconstruction. One recent study estimated surgeons were reimbursed $587 per hour for implants versus $322 for autologous reconstructive.
Ultimately, the observations provide insight to clinicians and policy-makers to help ensure equitable care is provided for women with breast cancer facing reconstructive procedures.
To learn more about the study, listen to a podcast with the authors.